A Clinician’s Guide to the Recognition and Management of Dupilumab-Associated Conjunctivitis
2019 · Drugs in R&D · 60 citations
https://doi.org/10.1007/s40268-019-00288-x
P
Peter Lio
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
424
Papers
6.3K
Citations
41
h-index
114
i10-index
Peter Lio is an academic researcher from Northwestern University. The author has contributed to research in topics: Dermatology and Skin Diseases & Allergic Rhinitis and Sensitization & Food Allergy and Anaphylaxis Research. The author has an h-index of 41, co-authored 361 publications.
ORCID: 0000-0001-7600-0152Papers by this author
worksCombining treat‐to‐target principles and shared decision‐making: International expert consensus‐based recommendations with a novel concept for minimal disease activity criteria in atopic dermatitis
2024 · Journal of the European Academy of Dermatology and Venereology · 58 citations
https://doi.org/10.1111/jdv.20229
Efficacy and safety of topically applied therapeutic ammonia oxidising bacteria in adults with mild-to-moderate atopic dermatitis and moderate-to-severe pruritus: a randomised, double-blind, placebo-controlled, dose-ranging, phase 2b trial
2023 · EClinicalMedicine · 35 citations
https://doi.org/10.1016/j.eclinm.2023.102002
Dupilumab in the management of topical corticosteroid withdrawal in atopic dermatitis: A retrospective case series
2018 · JAAD Case Reports · 26 citations
https://doi.org/10.1016/j.jdcr.2018.06.012
The association between obesity and efficacy of psoriasis therapies: An expert consensus panel
2024 · Journal of the American Academy of Dermatology · 12 citations
https://doi.org/10.1016/j.jaad.2024.12.016
Pediatric Topical Steroid Withdrawal Syndrome: What Is Known, What Is Unknown
2024 · Pediatric Dermatology · 10 citations
https://doi.org/10.1111/pde.15799
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat